|
Xceed's Dr. David Englert and Dr. Zhe Zhang of Children's Hospital of Philadelphia will present data at a luncheon workshop on
Wednesday, May 21st
[5/19/2008] WELLESLEY, Massachusetts (May 16, 2008) – Xceed Molecular, a pioneer in the development of cost-effective, easy-to-use
gene-expression analysis systems, announced that the company will feature its Ziplex Automated Gene-Expression System at Biomarker World Congress, booth 16. Currently
available for research use only in the US and Canada, the Ziplex System is the first integrated system for automated gene-expression analysis. It comprises an
automated hybridization workstation, TipChip consumable arrays, reagents, and analysis/reporting software. Biomarker World Congress takes place May 19-21, 2008, at
the Loews Philadelphia Hotel in Pennsylvania.
"Translational research (the movement of existing gene-expression biomarkers from basic science into routine clinical use for patient diagnostics) – and the ultimate
goal of personalized medicine – has been hampered because the available technology to process microarrays is complex, expensive, and time-consuming," said Xceed's
President and CEO, David Deems. "Results from traditional technology are also prone to unacceptable levels of variability to meet the rigorous performance and
quality-control needs of the clinical-diagnostic laboratory. Xceed designed the Ziplex System with turnkey functionality and significant advances in automation,
array format, fluidics, parallel sample processing, and analytics to minimize complexity, user interaction, and variability between users and sites. Our goal: to
make routine molecular diagnostics easy, reproducible, and affordable to serve the needs of both clinical research and clinical-diagnostic settings – which demand
that results remain consistent even when samples are run by different people, at different times, or in different sites."
Xceed is hosting a luncheon workshop from 12 to 1:30 pm, on Wednesday, May 21, 2008, in the Howe Room of the Loews Philadelphia Hotel.
Ziplex System for Focused Content, Multiplexed Gene-Expression Analysis – Introduction and Study Results David Englert, Ph.D., VP,
Technology Development, Xceed Molecular, Toronto.
Identification of a Diagnostic Classifier of Cornelia de Lange Syndrome, an Often Misdiagnosed and Little-Known Genetic Syndrome, Through a Stepwise
and Multi-Platform Procedure Zhe Zhang, Ph.D., Bioinformatics Core, Center for Biomedical Informatics, Children's Hospital of Philadelphia
Dr. Zhe Zhang is also presenting a poster on the subject, which will be available for viewing throughout the conference (Poster #11).
Xceed's vision is to advance molecular diagnostics by successfully translating novel multiplex tests into routine clinical practice and to create robust diagnostic
solutions to improve disease outcomes. Our products comprise the Ziplex® System for automated gene-expression analysis (available in the US and Canada for
research use only), gene expression services, and pre-configured arrays. Xceed is also developing multiplexed genomic tests for the Ziplex platform, both internally
and with strategic partners. Xceed’s R&D and manufacturing are headquartered in Toronto, Ontario, with executive offices in Wellesley, Massachusetts.
|
